Nonlinear dynamical analysis and optimization for biological/biomedical systems
Related Experiment Video
Updated: Jun 18, 2026

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors
Published on: July 28, 2023
1Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
As mathematical models are increasingly available for biological/biomedical systems, dynamic optimization can be a useful tool for manipulating systems. Dynamic optimization is a computational tool for finding a sequence of optimal actions to attain desired outcomes from the system. This chapter discusses two dynamic optimization algorithms, model predictive control and dynamic programming, in the context of finding optimal treatment strategy for correcting hypothalamic-pituitary-adrenal (HPA) axis dysfunction. It is shown that dynamic programming approach has the advantage over the model predictive control (MPC) methodology in terms of robustness to error in parameter estimates and flexibility of accommodating clinically relevant objective function.
Related Concept Videos
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Linear Approximation in Time Domain
For a simple pendulum with a mass evenly distributed along its length and the center of mass located at half the pendulum's length, the...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Analysis of Population Pharmacokinetic Data
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
